Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
GlySens Incorporated logo — company profile

GlySens Incorporated

Founded 1998 United States San Diego, United States 5 employees Series D Total: $34.00M Health Care, Manufacturing +1

General Information

Company Name GlySens Incorporated
Founded Year 1998
Location United States San Diego, United States
Employees 5
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with GlySens Incorporated. To contact GlySens Incorporated, visit glysens.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GlySens Incorporated compare?

A PDF of GlySens Incorporated and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GlySens Incorporated soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GlySens Incorporated

GlySens is a health care and manufacturing startup based in the United States. Founded in 1998, the company is committed to revolutionizing diabetes care with their long-term, implantable continuous glucose monitoring technology. Their flagship product, the Eclipse® ICGM® System, is the world's first truly long-term, wireless, implantable, continuous glucose monitor.

With a $20.00M Series D investment led by Windham Venture Partners in January 04, 2016, GlySens has demonstrated strong investor support. Their vision is to empower individuals with diabetes through worry-free, at-a-glance technologies that provide crucial information for optimizing care, while allowing for a more flexible lifestyle.

GlySens' continuous dedication to pushing the boundaries of diabetes care makes them a compelling venture for potential investors seeking opportunities in the health care and medical device sector.

Business keywords: Continuous Glucose Monitoring, Implantable Medical Device, Diabetes Technology, Glucose Sensor

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $20.00M 1
Windham Venture Partners
Windham Venture Partners
04 Jan 2016
Series C $12.00M -
05 Jan 2015
Grant $2.00M 1
National Institutes of Health
24 Nov 2014
Seed Round Undisclosed 1
West Health Investment Fund
West Health Investment Fund
14 Sep 2012

GlySens Incorporated Alternatives & Competitors

View All Alternatives
GlySens Incorporated vs
Senseonics, Incorporated
Senseonics, Incorporated United States

Advancing the future of diabetes management through innovative technology.

IPO
280 employees
Biotechnology, Hardware
Compare GlySens Incorporated vs Senseonics, Incorporated
GlySens Incorporated vs
Echo Therapeutics
Echo Therapeutics United States

Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) syst...

Post-IPO Debt
8 employees
Biotechnology, Health Care
GlySens Incorporated vs
GraphWear Technologies Inc.
GraphWear Technologies Inc. United States

#notblood

Series B
6 employees
Health Care, Medical Devices
Also compare with: GlySens Incorporated vs hillo hillo View all alternatives

FAQ About GlySens Incorporated

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the development of a long term, implantable continuous glucose monitoring technology. Since the company’s inception in 1998, we have focused on designing and developing the world’s first truly long term, wire...
GlySens Incorporated was founded in 1998.
GlySens Incorporated is headquartered in San Diego, United States.
GlySens Incorporated operates in Health Care, Manufacturing and Medical Devices. Its work centres on Continuous Glucose Monitoring, Implantable Medical Device, Diabetes Technology and Glucose Sensor.
GlySens Incorporated has approximately 5 employees.
GlySens Incorporated has completed 4 funding rounds, raising a total of $34.00M. The latest funding stage is Series D.
Top alternatives and competitors to GlySens Incorporated include Senseonics, Incorporated, Echo Therapeutics, GraphWear Technologies Inc., hillo, Apollon. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GlySens Incorporated and Senseonics, Incorporated are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GlySens Incorporated, https://bouncewatch.com/company/glysens, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes